Hentsch; Bernd

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hentsch; Bernd.The latest application filed is for "use of molecular markers for the preclinical profiling of inhibitors of enzymes having histone deacetylase activity".

Company Profile

0.3.23

Hentsch; Bernd - Frankfurt am Main DE
Hentsch; Bernd - Duisburg DE
Hentsch; Bernd - Munchen DE
HENTSCH; Bernd - Darmstadt DE
Hentsch; Bernd - Frankfurt/M DE
Hentsch; Bernd - Frankfurt DE
Hentsch, Bernd - Duisberg DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Molecular Markers For The Preclinical Profiling Of Inhibitors Of Enzymes Having Histone Deacetylase Activity App 20130231472 - HEINZEL; Thorsten ; et al.	2013-09-05
Compounds as histone deacetylase inhibitors Grant 8,227,516 - Maurer , et al. July 24, 2	2012-07-24
Using Inhibitors Of Histone Deacetylases For The Suppression Therapy Of Inherited Disease Predisposing Conditions App 20110092447 - Hentsch; Bernd ; et al.	2011-04-21
Using inhibitors of histone deacetylases for the suppression therapy of inherited disease predisposing conditions Grant 7,892,833 - Hentsch , et al. February 22, 2	2011-02-22
Use Of Valproic Acid For The Topical Treatment Of Mild To Moderate Acne Vulgaris App 20090186809 - Hentsch; Bernd ; et al.	2009-07-23
Inhibition Of Tristetraproline For Protection Of The Heart From Cardiac Injuries App 20090104182 - KLUXEN; Franz-Werner ; et al.	2009-04-23
Novel Compounds As Histone Deacetylase Inhibitors App 20090088478 - Maurer; Alexander B. ; et al.	2009-04-02
Use of Inhibitors of Histone Deacteylases in Combination With Compounds Acting as Nsaid for the Therapy of Human Diseases App 20080207724 - Mink; Sigrun ; et al.	2008-08-28
Identification of Human Gene Sequences of Cancer Antigens Expressed in Metastatic Carcinoma Involved in Metastasis Formation, and Their Use in Cancer Diagnosis, Prognosis and Therapy App 20080181894 - Mink; Sigrun ; et al.	2008-07-31
Use Of Carp Inhibitors For The Treatment Of Heart Diseases App 20070293579 - Kluxen; Franz-Werner ; et al.	2007-12-20
Using Inhibitors of Histone Deacetylases for the Suppression Therapy of Inherited Disease Predisposing Conditions App 20070037738 - Hentsch; Bernd ; et al.	2007-02-15
Human survivin interacting protein 1 (SIP-1) Grant 7,166,701 - Hentsch , et al. January 23, 2	2007-01-23
Larynx carcinoma-associated protein larcap-1 App 20060252157 - Ducker; Klaus ; et al.	2006-11-09
Novel Survivin interacting protein TPR1 App 20060127937 - Hentsch; Bernd ; et al.	2006-06-15
Use of molecular markers for the preclinical and clinical profiling of inhibitors of enzymes having histone deacetylase activity App 20060110735 - Heinzel; Thorsten ; et al.	2006-05-25
Novel compounds as histone deacetylase inhibitors App 20050176686 - Maurer, Alexander B. ; et al.	2005-08-11
Inhibition of tristetraproline for protection of the heart from cardiac injuries App 20050084860 - Kluxen, Franz-Werner ; et al.	2005-04-21
Novel survivin interacting protein tpr1 App 20050074839 - Hentsch, Bernd ; et al.	2005-04-07
Phosphodiesterase type 7b App 20050058647 - Kluxen, Franz-Werner ; et al.	2005-03-17
Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual disease App 20050038113 - Groner, Bernd ; et al.	2005-02-17
Human survivin interacting protein 1 (sip-1) App 20040254346 - Hentsch, Bernd ; et al.	2004-12-16
Novel protein inhibitor of apoptosis proteins App 20040072999 - Hentsch, Bernd	2004-04-15
Novel family member of inhibitor of apoptosis proteins App 20040039185 - Hentsch, Bernd	2004-02-26
Iapl-3 a novel protein inhibitor of apoptosis protein App 20040039166 - Hentsch, Bernd	2004-02-26
Use of carp inhibitors for the treatment of heart diseases App 20040014706 - Kluxen, Franz-Werner ; et al.	2004-01-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.